ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Martmarx Corp.

Martmarx Corp. (HMX)

0.00
0.00
(0.00%)
Al cierre: 05 Diciembre 3:00PM
0.00
0.00
( 0.00% )
Fuera de horario: -

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
-
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
-
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

HMX Últimas noticias

Hartmarx Shares Continue to be Listed on the Chicago Stock Exchange Following NYSE Delisting Action due to Non-Compliance With M

CHICAGO, Nov. 21 /PRNewswire-FirstCall/ -- Hartmarx Corporation (NYSE: HMX) today announced that on November 20, 2008, the Company was notified by the NYSE Regulation, Inc. ("NYSER") that the...

Hartmarx Third Quarter Results Continue to Be Adversely Impacted by Consumer Spending Slowdown and Retailers' Near-Term Negative

CHICAGO, Oct. 1 /PRNewswire-FirstCall/ -- Hartmarx Corporation (NYSE: HMX) today reported operating results for its third quarter and nine months ended August 31, 2008. Third quarter revenues...

/C O R R E C T I O N -- Hartmarx Corporation/

In the news release, Hartmarx Second Quarter Results Adversely Impacted by On-Going Consumer Spending Slowdown, in the first table, the headings for the first two columns should read 2008 and...

Hartmarx Second Quarter Results Adversely Impacted by On-Going Consumer Spending Slowdown

CHICAGO, June 30 /PRNewswire-FirstCall/ -- Hartmarx Corporation (NYSE:HMX) today reported operating results for its second quarter and six months ended May 31, 2008. Second quarter revenues were...

Hart Schaffner Marx, Sansabelt and Pierre Cardin Brands to be Marketed in India

CHICAGO, May 7 /PRNewswire-FirstCall/ -- Hartmarx Corporation (NYSE:HMX) today announced agreement with The Arvind Mills Limited to market and retail in India its owned Hart Schaffner Marx and...

Hartmarx Corporation Appoints Jerry Kaye as Head Designer of Dr. Martens and Lyle and Scott Vintage Apparel

CHICAGO, May 6 /PRNewswire-FirstCall/ -- Hartmarx Corporation (NYSE:HMX) announced today that Jerry Kaye has been named Head Designer of the Dr. Martens(R) and Lyle and Scott Vintage apparel...

Hartmarx Announces Dr. Martens Sportswear License

CHICAGO, April 16 /PRNewswire-FirstCall/ -- Hartmarx Corporation (NYSE: HMX) today announced that it has reached agreement with Airwair International Limited and R Griggs Group Limited, the...

Hartmarx First Quarter Results in Line With Previous Guidance

CHICAGO, March 27 /PRNewswire-FirstCall/ -- Hartmarx Corporation (NYSE:HMX) today reported operating results for its first quarter ended February 29, 2008. Sales were $119.1 million in 2008...

Mexico Day at the New York Stock Exchange

NEW YORK, March 19 /PRNewswire/ -- The NYSE Euronext, The Bank of New York Mellon and Grayling Global will be hosting "Mexico Day" on Tuesday, March 25, 2008. This event, that will take place at...

Hartmarx Reports Fourth Quarter and Full Year Results in Line With Most Recent Guidance; Reaffirms Most Recent Revenue and Earni

CHICAGO, Jan. 28 /PRNewswire-FirstCall/ -- Hartmarx Corporation (NYSE:HMX) today reported operating results for its fourth quarter and fiscal year ended November 30, 2007. Full year net sales...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
LEVLion Electric Company
US$ 0.60
(79.10%)
5.63M
RBRKRubrik Inc
US$ 63.63
(18.58%)
931.1k
ASANAsana Inc
US$ 18.00
(16.43%)
1.21M
VEEVVeeva Systems Inc
US$ 249.00
(7.49%)
74.34k
CANGCango Inc
US$ 4.47
(6.43%)
694
IOTSamsara Inc
US$ 49.1018
(-10.93%)
646.11k
PATHUiPath Inc
US$ 13.95
(-6.69%)
4.5M
TPLTexas Pacific Land Corporation
US$ 1,279.31
(-5.00%)
940
WLTGWealthtrust Dbs Long Term Growth ETF
US$ 29.28
(-4.99%)
516
TVGrupo Televisa SA
US$ 1.91
(-4.98%)
6.01k
NIONIO Inc
US$ 4.63
(0.43%)
46.73M
XPEVXPeng Inc
US$ 12.58
(0.24%)
15.3M
LEVLion Electric Company
US$ 0.60
(79.10%)
5.63M
UMCUnited Microelectronics Corp
US$ 6.60
(0.15%)
5.31M
PATHUiPath Inc
US$ 13.95
(-6.69%)
4.5M
LCJR LCJR 4 minutos hace
Most don't even know what XRP is, much less know the value. No rug pull here, everyone just needs patience and let it play out.

LCJR

XRPUSD
Info3 Info3 4 minutos hace
In general 
BMXI
misterfishman misterfishman 5 minutos hace
Nice day today.
RDAR
MartinLutherKing MartinLutherKing 5 minutos hace
8. TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data
October 23 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company co
RNAZ
sluggercjb sluggercjb 5 minutos hace
lol Orca has the Doc. And all shareholders running scared all those threats are keeping everyone up at night. Orca Please stop being a bully lol ..still get a good laugh at his post
VDRM
LCP77 LCP77 5 minutos hace
I meet twice a year with my tax advisor (CPA). Once about now, for year end positioning, and then for tax season. I’ve found that to be worthwhile.
NB
bananarama bananarama 7 minutos hace
Forget about a five dollar BO. After yesterday's Web Conference, that price has already jumped to at least ten dollars. If some white knight waits to buy KBLB, they will be paying twice that amount. GO KBLB!
KBLB
nt2innovate nt2innovate 7 minutos hace
Yes. Good call. Hopefully buying will increase on the OTC with retail and family offices if they start seeing 30-40% annual growth rates going forward without dilution as you said which will cause the stock price to go up significantly.

The idea of the PEC along with Enclave having va
SDCH
northam43 northam43 7 minutos hace
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/5/stiec6.1_Short_Term.png
jsc52033 jsc52033 7 minutos hace
actualy its down 3,397 from yesterday yet yes way ahead of Tueday which was almost none at 150,000 +
BMXI
MartinLutherKing MartinLutherKing 7 minutos hace
6.TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
September 17 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer usin
RNAZ
fwb fwb 8 minutos hace
If it's McDonald NEWS, we could go higher than $20.00
SOUN
XenaLives XenaLives 8 minutos hace
Define "e" as massive AI manipulation of the market as a whole....
AVXL
band aid band aid 8 minutos hace
Does anyone think they will figure out how to sell a few more trinkets then they have in the past. I guess we shall see in the once a year financial reports. Then maybe the company may have a couple of bucks in the bank.
BIEL
northam43 northam43 8 minutos hace
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/5/stiec6.1_Short_Term.png
zab zab 9 minutos hace
The trump clown show is in full display for everyone to see, another reason only 49 percent of America voted for orange shittypants.  But remember trump will blame everyone else for his daily mistakes,  and meltdowns.
MartinLutherKing MartinLutherKing 9 minutos hace
5.TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer
September 10 2024 - 7:00AM


TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology compan
RNAZ
misterfishman misterfishman 9 minutos hace
There is plenty of frustration going on over here mostly due to impatience peeps this stock is a longterm play like a few years out if peeps can't wait then sell.its that simple.
IGPK
bananarama bananarama 9 minutos hace
I totally agree with you, Monkey! Any company interested in buying KBLB would recognize that it is better to buy the company now rather than wait for it to reach the Texas Exchange (or the NASDQ). Then, the BO price will be MUCH MUCH higher. GO KBLB! ;-)
KBLB
MartinLutherKing MartinLutherKing 10 minutos hace
4.TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
September 05 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today an
RNAZ

Su Consulta Reciente

Delayed Upgrade Clock